Literature DB >> 12826851

Differential uptake of volatile agents into brain tissue in vitro. Measurement and application of a diffusion model to determine concentration profiles in brain slices.

Michael A Chesney1, Misha Perouansky, Robert A Pearce.   

Abstract

BACKGROUND: The rate of onset of drug actions in experiments with brain slices in vitro can vary widely. One factor that influences the rate is access to tissue sites of action. To study the effects of the nonimmobilizer 1,2-dichlorohexafluorocyclobutane (F6, also termed 2N in the literature) on physiologic processes under defined tissue concentrations, the authors performed electrophysiologic measurements of the effects of F6 and halothane, measured the uptake of these agents into brain tissue, and performed computational modeling to determine concentration-depth profiles during drug application.
METHODS: Hippocampal brain slices 500 microm thick were prepared from adult rats. Evoked population responses in the CA1 region were obtained using extracellular recordings and electrical stimulation of the Schaffer collateral pathway. F6 (24 microm) and halothane (270 microm) were applied via superfusion for 40 min. Uptake of drug into tissue slices was measured using gas chromatography. Computational modeling was used to obtain estimates of drug diffusion coefficients in brain tissue and to calculate tissue concentration as a function of time and depth during drug application.
RESULTS: Halothane reduced the amplitude of the evoked population spike and reduced the population excitatory postsynaptic potential slope. F6 had no effect on either measure. Uptake experiments yielded a diffusion coefficient of 0.1 x 10-6 cm2/s for F6 and 0.8 x 10-6 cm2/s for halothane. After 40 min of drug application, the concentration reached at tissue depths from which physiologic signals were obtained, approximately the top 200 microm of the slice, was estimated to be 58% of the final equilibrium value for F6 and 93% for halothane.
CONCLUSIONS: Diffusion into tissue is substantially slower for F6 than for halothane, and its impact is great enough that this must be considered when designing or interpreting in vitro experiments. However, impaired access does not account for the lack of effect of F6 on electrophysiologic responses in rat hippocampal slices.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12826851     DOI: 10.1097/00000542-200307000-00021

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

1.  Slowing of the hippocampal θ rhythm correlates with anesthetic-induced amnesia.

Authors:  Misha Perouansky; Vinuta Rau; Tim Ford; S Irene Oh; Mark Perkins; Edmond I Eger; Robert A Pearce
Journal:  Anesthesiology       Date:  2010-12       Impact factor: 7.892

2.  Noninvasive Ultrasonic Drug Uncaging Maps Whole-Brain Functional Networks.

Authors:  Jeffrey B Wang; Muna Aryal; Qian Zhong; Daivik B Vyas; Raag D Airan
Journal:  Neuron       Date:  2018-11-07       Impact factor: 17.173

Review 3.  Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment.

Authors:  E S Vizi; A Fekete; R Karoly; A Mike
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

4.  Mechanisms of inhibition of CaV3.1 T-type calcium current by aliphatic alcohols.

Authors:  Veit-Simon Eckle; Slobodan M Todorovic
Journal:  Neuropharmacology       Date:  2010-04-02       Impact factor: 5.250

5.  Inhibition of T-type calcium current in rat thalamocortical neurons by isoflurane.

Authors:  Veit-Simon Eckle; Michael R Digruccio; Victor N Uebele; John J Renger; Slobodan M Todorovic
Journal:  Neuropharmacology       Date:  2012-04-02       Impact factor: 5.250

6.  Distinctive recruitment of endogenous sleep-promoting neurons by volatile anesthetics and a nonimmobilizer.

Authors:  Bo Han; Hilary S McCarren; Dan O'Neill; Max B Kelz
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

7.  Enhancement of α5-containing γ-aminobutyric acid type A receptors by the nonimmobilizer 1,2-dichlorohexafluorocyclobutane (F6) is abolished by the β3(N265M) mutation.

Authors:  Paul M Burkat; Chong Lor; Misha Perouansky; Robert A Pearce
Journal:  Anesth Analg       Date:  2014-12       Impact factor: 5.108

8.  Anesthetic agent-specific effects on synaptic inhibition.

Authors:  M Bruce MacIver
Journal:  Anesth Analg       Date:  2014-09       Impact factor: 5.108

9.  Isoflurane Potentiation of GABAA Receptors Is Reduced but Not Eliminated by the β3(N265M) Mutation.

Authors:  Chong Lor; Misha Perouansky; Robert A Pearce
Journal:  Int J Mol Sci       Date:  2020-12-15       Impact factor: 5.923

10.  Determination of Diffusion Kinetics of Ketamine in Brain Tissue: Implications for in vitro Mechanistic Studies of Drug Actions.

Authors:  Zachary Geiger; Brett VanVeller; Zarin Lopez; Abdel K Harrata; Kathryn Battani; Lauren Wegman-Points; Li-Lian Yuan
Journal:  Front Neurosci       Date:  2021-07-01       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.